biote Corp. (BTMD) CEO awarded 441,653 stock options at $1.43 strike price

Rhea-AI Filing Summary

biote Corp. reported that Chief Executive Officer Bret Christensen received a grant of employee stock options. The award covers 441,653 options to buy Class A Common Stock at an exercise price of $1.43 per share, all held as direct ownership.

According to the vesting terms, 25% of the options will vest on April 1, 2027. The remaining options will then vest in 36 substantially equal monthly installments, contingent on Christensen’s continuous service through each vesting date. No open‑market purchases or sales were reported in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Christensen Bret

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	441,653	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 441,653 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 441,653 options Exercise price: $1.43 per share Shares underlying options: 441,653 shares +3 more

6 metrics

Option grant size 441,653 options Employee stock option award to CEO Bret Christensen

Exercise price $1.43 per share Strike price for Class A Common Stock underlying options

Shares underlying options 441,653 shares Class A Common Stock covered by the option grant

Vesting cliff date April 1, 2027 25% of options vest on this date, subject to service

Remaining vesting schedule 36 monthly installments After April 1, 2027, remaining options vest monthly

Option expiration March 31, 2036 Expiration date of the employee stock options

Key Terms

Employee Stock Option (Right to Buy), Class A Common Stock, vesting

3 terms

Employee Stock Option (Right to Buy) financial

"security_title: "Employee Stock Option (Right to Buy)""

Class A Common Stock financial

"underlying_security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"25% of the shares subject to the option shall vest on April 1, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Christensen Bret

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$1.43	04/01/2026		A		441,653		(1)	03/31/2036	Class A Common Stock	441,653	$0.00	441,653	D

Explanation of Responses:

1. 25% of the shares subject to the option shall vest on April 1, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Bret Christensen	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did biote Corp. (BTMD) CEO Bret Christensen report in this Form 4?

Bret Christensen reported receiving 441,653 employee stock options to buy biote Corp. Class A Common Stock at $1.43 per share. These options are a compensation award and do not represent an open-market purchase or sale of existing BTMD shares.

What are the main terms of Bret Christensen’s new stock option grant at biote Corp. (BTMD)?

The option grant covers 441,653 shares of Class A Common Stock with a $1.43 exercise price. The options were granted at no cost and are held directly. They are structured as an employee stock option (right to buy) with long-term vesting conditions attached.

How do Bret Christensen’s biote Corp. (BTMD) stock options vest over time?

Twenty-five percent of the options vest on April 1, 2027, if service continues. The remaining 75% then vest in 36 substantially equal monthly installments thereafter, subject to Christensen maintaining continuous service through each monthly vesting date with biote Corp.

Do these biote Corp. (BTMD) Form 4 transactions involve any stock sales?

No, the Form 4 only reports a grant of employee stock options to Bret Christensen, not stock sales. The transaction is classified as a grant or award acquisition, meaning it reflects compensation rather than an open-market purchase or sale of BTMD shares.

What is the expiration date of Bret Christensen’s biote Corp. stock options?

The employee stock options are scheduled to expire on March 31, 2036, if not exercised earlier. This long expiration period gives Christensen a substantial time window to potentially exercise the options once they vest and if conditions for exercise are met.